Glucosanol 500mg

DIETARY_SUPPLEMENT2 trials

Sponsors

InQpharm Group

Conditions

Hyperglycemia, PostprandialOverweight and Obesity

Unknown Phase

Efficacy and Safety of Glucosanol™ in Body Weight Reduction

CompletedNCT02930668

InQpharm GroupOverweight and Obesity

Start: 2016-05-31End: 2016-11-30Updated: 2023-07-27

Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects

CompletedNCT02930681

InQpharm GroupHyperglycemia, Postprandial

Start: 2016-08-31End: 2016-11-30Updated: 2017-02-08

Related Papers

Proprietary alpha-amylase inhibitor formulation from white kidney bean (Phaseolus vulgaris L.) promotes weight and fat loss: a 12-week, double-blind, placebo-controlled, randomized trial

Scientific Reports2024-06-0314 citations